For five years, insulin manufacturer Novo Nordisk agrees to cap out-of-pocket cost of its insulin treatments at $35 per month, and provide free insulin to the neediest Minnesotans.
The White House’s decision to pause federal grants and loans has sent shockwaves across Washington, D.C., and beyond, exposing vulnerabilities in Republican-leaning states that heavily depend on ...